Members Only Content
Subscribe to get full access
Free Preview
The phage therapy pioneer expects multiple data readouts this year. It needs positive results and successful developments so that it can raise cash.
Upstart Recommendation Report Upstart Presentation Slides
Lemonade (NYSE: LMND) is a new player who's really adding zest to the insurance industry. Its AI-powered underwriting enables it to [...]
PubMatic just reported first quarter 2025 results. Aside from the headwinds of a DSP partner changing its bidding process, the [...]
